Cleveland HeartLab gains cardiovascular diagnostic from Stanford
Cleveland HeartLab LLC (CHL) acquired Stanford University School of Medicine’s MIRISK tool for assessing the long-term risk for...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly review of licensing agreements between companies and universities or other research institutions in the In Vitro Diagnostics, Medical Device, and Pharmaceutical sectors. This month’s column covers deals announced December 2014 through January 2015.
Cleveland HeartLab gains cardiovascular diagnostic from Stanford
Cleveland HeartLab LLC (CHL) acquired Stanford University School of Medicine’s MIRISK tool for assessing the long-term risk for...